Lucentis (ranibizumab injection)
LUCENTIS (ranibizumab injection) – an biologic monoclonal antibody commonly used to treat certain eye conditions. Ranibizumab binds to the receptor binding site of active forms of VEGF-A, including the biologically active, cleaved form of this molecule, VEGF110. VEGF-A has been shown to cause neovascularization and leakage in models of ocular angiogenesis and vascular occlusion and […]